Skip to content

Clinical trials

Phase 3 Arthritis, Rheumatoid trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 3 Country / region: United States Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20026
20033
20042
200515
20065
200713
20085
200914
201012
201111
201212
201310
20146
201511
201612
20175
20182
20192
20203
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed137
Terminated16
Active, not recruiting4
Unknown status3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche16
Bristol-Myers Squibb15
Eli Lilly and Company10
Pfizer10
Amgen9
UCB Pharma9
AbbVie7
Sanofi6
Abbott5
Boehringer Ingelheim5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid162
Arthritis20
Joint Diseases10
Osteoarthritis8
Musculoskeletal Diseases6
Autoimmune Diseases4
Complex Regional Pain Syndromes3
Chronic Pain2
Connective Tissue Diseases2
Fibromyalgia2

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.